Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Verve Therapeutics
Verve Therapeutics
First look at Verve study data offer base editing ‘proof of principle’
BioPharma Dive
Sun, 11/12/23 - 09:27 pm
Verve Therapeutics
heart disease
gene editing
Lilly buys Beam’s option on Verve drug programs
Pharmaforum
Tue, 10/31/23 - 10:06 am
Eli Lilly
gene editing
Beam Therapeutics
Verve Therapeutics
Verve gets FDA green light to run base editing study in US
BioPharma Dive
Mon, 10/23/23 - 05:01 pm
Verve Therapeutics
FDA
gene editing
heart disease
clinical trials
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
Verve partners with Lilly on gene editing therapy for heart disease
BioPharma Dive
Thu, 06/15/23 - 10:02 am
Eli Lilly
Verve Therapeutics
heart disease
gene editing
FDA Outlines Path Forward for Verve’s Lead Candidate, VERVE-101
BioSpace
Mon, 12/5/22 - 10:55 pm
Verve Therapeutics
VERVE-101
FDA
heterozygous familial hypercholesterolemia
Do Verve's gene edits pass down to patients' children? The FDA wants to know
Fierce Biotech
Mon, 12/5/22 - 10:42 am
Verve Therapeutics
gene editing
gene therapy
FDA
VERVE-101
FDA Pauses Verve’s Trial Plan for Gene-Editing Therapy for High Cholesterol
MedCity News
Mon, 11/7/22 - 05:17 pm
Verve Therapeutics
gene editing
FDA
heterozygous familial hypercholesterolemia
VERVE-101
HeFH
Vertex, Verve team up to develop a gene editing drug for liver disease
Biopharma Dive
Wed, 07/20/22 - 11:24 pm
Vertex Pharma
Verve Therapeutics
liver disease
Biotech listings shows few signs of cooling
EP Vantage
Fri, 07/2/21 - 10:53 am
biotech
IPOs
Lyell Immunopharma
Recursion Pharmaceuticals
Centessa Pharmaceuticals
Verve Therapeutics
Graphite Bio
Another four IPOs complete busy week as biotech raise continues to match 2020's record pace
Endpoints
Fri, 06/18/21 - 10:06 am
IPOs
Lyell Immunopharma
Verve Therapeutics
Molecular Partners
ATAI Life Sciences
Century Therapeutics
Ambrx
Cyteir Therapeutics
Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO
Fierce Biotech
Tue, 06/1/21 - 10:50 pm
Verve Therapeutics
IPOs
gene editing
heart disease
Beam, Verve stockpile cash as investors bank on gene editing progress
BioPharma Dive
Tue, 01/19/21 - 09:13 pm
Beam Therapeutics
Verve Therapeutics
gene editing
funding
JPM: Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
Fierce Biotech
Tue, 01/12/21 - 11:11 am
JPMHC 2021
Verve Therapeutics
VERVE-101
familial hypercholesterolemia
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Stat
Sun, 06/28/20 - 07:10 pm
CRISPR
Verve Therapeutics
stem cells
cholesterol
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes
Xconomy
Thu, 06/11/20 - 11:17 am
gene editing
Verve Therapeutics
heart attacks
familial hypercholesterolemia
Google Jumps Into Gene Editing: 5 Things You Need to Know
Motley Fool
Mon, 05/13/19 - 10:20 am
Google
gene editing
Verily
Verve Therapeutics
Alphabet
nanoparticles
One of the world’s top experts in coronary heart disease is spearheading a new gene editing upstart out to transform the field
Endpoints
Tue, 05/7/19 - 06:54 pm
Verve Therapeutics
Sekar Kathiresan
gene therapy